List of works - Jonathan A Fallowfield

A phase 2 randomised controlled trial of serelaxin to lower portal pressure in cirrhosis (STOPP)

scientific article published on 12 March 2020

Assessment of Haemodynamic Response to Nonselective Beta-Blockers in Portal Hypertension by Phase-Contrast Magnetic Resonance Angiography

scientific article published on 15 June 2017

Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial

scientific article published on 10 January 2025

Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study

scientific article published on 20 May 2020

Editorial: getting bullish about portal hypertension-chronic treatment with oral taurine?

scientific article published in February 2018

In search of a small molecule agonist of the relaxin receptor RXFP1 for the treatment of liver fibrosis.

scientific article published on 7 September 2017

Models and Mechanisms of Fibrosis Resolution ⬇️

scientific article published on February 1, 2011

Multiparametric magnetic resonance imaging for quantitation of liver disease: a two-centre cross-sectional observational study.

scientific article

Non-invasive assessment of liver disease in rats using multiparametric magnetic resonance imaging: a feasibility study

scientific article published on 02 July 2018

Non-invasive risk scores do not reliably identify future cirrhosis or hepatocellular carcinoma in Type 2 diabetes: The Edinburgh Type 2 Diabetes Study

scientific article published on 07 July 2020

Noninvasive Evaluation of Portal Hypertension: Emerging Tools and Techniques ⬇️

scientific article published on June 7, 2012

Pathogenesis and treatment of hepatic fibrosis: is cirrhosis reversible? ⬇️

scientific article published on April 1, 2011

Quantitative magnetic resonance imaging predicts individual future liver performance after liver resection for cancer

scientific article published on 02 December 2020

Resolving the fibrotic niche of human liver cirrhosis at single-cell level

scientific article published on 09 October 2019

Safety profile of autologous macrophage therapy for liver cirrhosis

scientific article published on 07 October 2019

Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial